The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global optical coherence tomography market reached a value of US$ 1.41 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.16 Billion by 2027, exhibiting a CAGR of 13.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Optical coherence tomography (OCT) refers to a non-invasive imaging technique used to obtain high-resolution cross-sectional images of the retina. Tabletop and handheld are some of the commonly available types of OCT devices. They consist of an interferometer and short-pulse lasers with low coherence and a broad bandwidth light source. OCT is widely used in various healthcare domains, such as ophthalmology, oncology, cardiovascular, and dermatology. It is also used to detect the retinal thickness and aids in the early detection and diagnosis of retinal diseases and conditions. It also provides precise imaging of neointimal stent strut coverage in follow-up exams and assists in the easier evaluation of stent strut apposition against the vessel wall.
The increasing incidences of retinal and choroidal disorders and visual impairments across the globe are creating a positive outlook for the market. Optical coherence tomography is widely used by an ophthalmologist for screening and diagnosing retinal-related disorders, including tear and detachment, diabetic retinopathy, macular hole, and retinitis pigmentosa. Apart from this, various product innovations, such as the introduction of higher-performing devices that assist in enhancing accuracy and improving the overall quality of eye care, are providing an impetus to the market growth. Additionally, the increasing geriatric population and rising instances of cancer are also favoring the market growth. Optical coherence tomography aids in early cancer detection and provides information on nuclear-to-cytoplasmic ratio, nuclear size and shape, and the organization and structure of glands. Other factors, including the increasing demand for early diagnosis methods, widespread product utilization in drug delivery, and significant improvements in healthcare technologies, are anticipated to drive the market further toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global optical coherence tomography market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, technology and application.
Breakup by Type:
Breakup by Technology:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agfa-Gevaert N.V., Agiltron Inc., Carl Zeiss AG, Haag-Streit Group, Heidelberg Engineering Inc., Leica Microsystems GmbH (Danaher Corporation), Novacam Technologies Inc., OPTOPOL Technology Sp. z o.o., Terumo Corporation, Thorlabs Inc. and Topcon Corporation.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Technology, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, Agfa-Gevaert N.V., Agiltron Inc., Carl Zeiss AG, Haag-Streit Group, Heidelberg Engineering Inc., Leica Microsystems GmbH (Danaher Corporation), Novacam Technologies Inc., OPTOPOL Technology Sp. z o.o., Terumo Corporation, Thorlabs Inc. and Topcon Corporation.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at